Takeda? Or are you still thinking Bayer AG? Maybe they can announce at Camerino (Italy) and BOOM - together the Axis will reunite, but for the good of humanity THIS time!
"I am also convinced the little redhead did not go to the ball without her suitor waiting and ready. We'd still be OTC. "
But didn't AVXL report a month or two ago that the Donopezil adjunct group was (surprisingly) no longer showing greater efficacy than the Anavex 2-73 monotherapy group? Or am I remembering that wrong... or did I misunderstand?
Or is the guy in the Tuxedo maybe someone other than Eisai Co. or Pfizer?
News 
Market Data 
Discover 
AI
